Investigational Drug Information for ADX-71149
✉ Email this page to a colleague
What is the development status for investigational drug ADX-71149?
ADX-71149 is an investigational drug.
There have been 22 clinical trials for ADX-71149.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 15th 2019.
The most common disease conditions in clinical trials are Syndrome, Sleepiness, and Narcolepsy. The leading clinical trial sponsors are Aldeyra Therapeutics, Inc., Jazz Pharmaceuticals, and Q32 Bio Inc.
There are two US patents protecting this investigational drug and forty international patents.
Summary for ADX-71149
| US Patents | 2 |
| International Patents | 40 |
| US Patent Applications | 24 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 3 (2019-11-15) |
| Vendors | 42 |
Recent Clinical Trials for ADX-71149
| Title | Sponsor | Phase |
|---|---|---|
| Safety, Tolerability, PK and PD of ADX-038 in HV and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients | ADARx Australia Pty Ltd | Phase 1 |
| Safety, Tolerability, PK and PD of ADX-038 in HV and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients | ADARx Pharmaceuticals, Inc. | Phase 1 |
| A Clinical Trial in Subjects With Atopic Dermatitis (Part 1) | Aldeyra Therapeutics, Inc. | Phase 2 |
Clinical Trial Summary for ADX-71149
Top disease conditions for ADX-71149
Top clinical trial sponsors for ADX-71149
US Patents for ADX-71149
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ADX-71149 | ⤷ Try a Trial | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4'] bipyridinyl-2'-ones | Janssen Pharmaceuticals, Inc. (Titusville, NJ) Addex Pharma SA (Geneva, CH) | ⤷ Try a Trial |
| ADX-71149 | ⤷ Try a Trial | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2- '-ones | Janssen Pharmaceuticals, Inc. (Titusville, NJ) Addex Pharma SA (Geneva, CH) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ADX-71149
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ADX-71149 | Argentina | AR068511 | 2027-09-14 | ⤷ Try a Trial |
| ADX-71149 | Austria | AT496906 | 2027-09-14 | ⤷ Try a Trial |
| ADX-71149 | Australia | AU2008297878 | 2027-09-14 | ⤷ Try a Trial |
| ADX-71149 | Brazil | BRPI0816767 | 2027-09-14 | ⤷ Try a Trial |
| ADX-71149 | Canada | CA2696948 | 2027-09-14 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
